Overcoming challenges in obesity-related clinical trialsĀ
Drug Discovery World
APRIL 10, 2024
Recent advancements in obesity treatments, exemplified by the approvals of semaglutide and tirzepatide, have spotlighted the field for healthcare providers and developers. Deirdre Albertson , Vice President, Project Management, Cardiovascular/Metabolic Division, ICON, Jack L.
Let's personalize your content